Autolus Therapeutics PLC Sponsored ADR (AUTL) vs Entera Bio Ltd. (ENTX)

Autolus Therapeutics PLC Sponsored ADR and Entera Bio Ltd. are both Biotechnology companies. Autolus Therapeutics PLC Sponsored ADR and Entera Bio Ltd. are of similar size ($481.8M and $462.4M). Autolus Therapeutics PLC Sponsored ADR grew revenue faster over the last twelve months: 193.3% against 66.4%. Entera Bio Ltd. has the higher net margin (0.00% vs −238.7%) and the higher return on invested capital (0.00% vs 0.00%). Across the 17 metrics below, Autolus Therapeutics PLC Sponsored ADR leads on 9 and Entera Bio Ltd. on 8.

Valuation

Metric AUTL ENTX Biotechnology median
P/E n/m n/m 8.56
P/S 3.95 599.53 10.17
P/B 6.19 18.40 2.34
Price to free cash flow n/m n/m 20.42
EV/EBITDA n/m n/m 0.69
EV/Sales 2.88 534.34 9.64
Earnings yield (60.92%) (13.21%) (29.41%)
Free cash flow yield (54.82%) (8.22%) (23.50%)

Profitability

Metric AUTL ENTX Biotechnology median
Gross margin 15.66% 0.00% 65.16%
Operating margin (210.78%) 0.00% 0.00%
Net margin (238.66%) 0.00% 0.00%
Free cash flow margin (198.26%) 0.00% 0.00%
Return on equity (133.00%) (138.92%) (56.66%)
Return on assets (46.15%) (87.02%) (49.22%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric AUTL ENTX Biotechnology median
Revenue growth (TTM) 193.29% 66.42% 5.64%
EPS growth (last fiscal year) (25.58%) 0.00% 30.08%
Revenue growth, 5-year CAGR 113.11% (29.19%) 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric AUTL ENTX Biotechnology median
Debt to equity 1.04 0.00 0.00
Current ratio 4.89 8.98 4.72
Net debt to EBITDA 1.16 1.29 0.96

Dividend

Metric AUTL ENTX Biotechnology median
Dividend yield — — 0.08%
Payout ratio — — —

Size

Metric AUTL ENTX Biotechnology median
Market cap 481.75m 462.40m 151.40m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack